Development Level

Tbio 18 | 11,445
Tchem 2 | 1,598
Tdark 2 | 6,588

IMPC Phenotype

abnormal body wall morphology 1 | 9
abnormal embryo size 1 | 220
abnormal facial morphology 1 | 17
abnormal head shape 1 | 10
abnormal limb morphology 1 | 13
abnormal tail morphology 1 | 25
cleft palate 1 | 8
edema 1 | 59
preweaning lethality, complete... 1 | 979
protruding tongue 1 | 3
unresponsive to tactile stimul... 1 | 8

Disease

Carcinoma 19 | 11,493
psoriasis 12 | 6,694
Sickle Cell Anemia 9 | 53
Anemia 8 | 365
Bilirubin metabolic disorder 8 | 41
Pericholangitis 7 | 8
Cancer 5 | 2,499
Attention deficit hyperactivity disorder 4 | 278
ovarian cancer 4 | 8,520
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
colon cancer 3 | 1,478
glioblastoma 3 | 5,792
osteosarcoma 3 | 7,950
ulcerative colitis 3 | 1,819
Acute kidney injury 2 | 70
Autosomal recessive predisposition 2 | 1,442
Breast cancer 2 | 3,578
Cholelithiasis 2 | 33
Cholestasis 2 | 155
Contact Dermatitis 2 | 81
Crigler Najjar syndrome, type 1 2 | 2
Crigler Najjar syndrome, type 2 2 | 2
Dermatitis, Contact 2 | 71
Diarrhea 2 | 253
Dihydropyrimidine dehydrogenase deficiency 2 | 6
Epilepsy 2 | 792
Gilbert syndrome 2 | 3
Kernicterus 2 | 11
Kidney cancer 2 | 2,613
Melanoma 2 | 711
Neonatal Jaundice 2 | 30
Neutropenia 2 | 72
Prostate cancer 2 | 175
Prostatic Neoplasms 2 | 495
Thalassemia 2 | 53
Urinary bladder cancer 2 | 36
active ulcerative colitis 2 | 764
atypical teratoid / rhabdoid tumor 2 | 5,112
facioscapulohumeral dystrophy 2 | 288
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
primitive neuroectodermal tumor 2 | 3,035
Abnormality of the fingernails 1 | 51
Acquired immunodeficiency syndrome 1 | 197
Adenocarcinoma 1 | 122
Adverse reaction to drug 1 | 61
BILIARY TRACT ABNORMALITY 1 | 16
Barrett's esophagus 1 | 182
Big calvaria 1 | 147
Biliary Tract Diseases 1 | 16
Bladder Neoplasm 1 | 112
Brachydactyly 1 | 156
Carcinoma, Small Cell 1 | 9
Cerebral palsy 1 | 40
Chemical and Drug Induced Liver Injury 1 | 195
Craniofacial Abnormalities 1 | 151
Decreased projection of midface 1 | 105
Drug-Related Side Effects and Adverse Reactions 1 | 62
Encephalopathies 1 | 43
Fascioliasis 1 | 17
Fibular hypoplasia 1 | 9
Galactosemia 1 | 19
Graft vs Host Disease 1 | 6
Graft-vs-Host Disease 1 | 5
Hooked clavicle 1 | 5
Hypoplastic ilia 1 | 12
Hypoplastic toenails 1 | 22
Hypotrophic malar bone 1 | 129
Hypotrophic midface 1 | 105
Icterus 1 | 82
Increased fibular diameter 1 | 4
Increased head circumference 1 | 147
Increased size of cranium 1 | 147
Increased size of skull 1 | 147
Infantile muscular hypotonia 1 | 12
Liver disease 1 | 237
Long narrow head 1 | 75
Lymphatic obstruction 1 | 21
Lymphedema 1 | 42
Malar flattening 1 | 129
Metaphyseal irregularity 1 | 23
Midface retrusion 1 | 105
Narrow cranium shape 1 | 75
Narrow head shape 1 | 75
Narrow skull shape 1 | 75
Narrow thorax 1 | 53
Onset of lymphedema around puberty 1 | 21
Pain agnosia 1 | 104
Polyhydramnios 1 | 108
Prolonged neonatal jaundice 1 | 17
Retinitis pigmentosa 28 1 | 19
Short limb dwarfism, disproportionate 1 | 22
Short ribs 1 | 30
Small midface 1 | 105
Small wings of the pelvic girdle 1 | 12
Stillbirth 1 | 17
Turridolichocephaly 1 | 75
Unconjugated hyperbilirubinemia 1 | 4
Urinary Bladder Neoplasms 1 | 114
drug-induced hepatitis 1 | 44

Tissue

Digestive Tract 22 | 17,369
Liver and Pancreas 22 | 16,750
Urinary Tract 20 | 16,678
Skin and soft tissues 19 | 17,230
Male tissues 17 | 17,142
Female tissues 16 | 17,400
Endocrine System 15 | 18,159
Blood and immune system 13 | 16,909
Nervous System 10 | 16,725
Respiratory system 8 | 16,393
Cardiovascular System 5 | 15,192

Target Family

Enzyme 21 | 4,145
Transporter 1 | 473

Reactome Pathway

Glucuronidation 22 | 22
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
UDP-glucuronosyltransferase 2B7 UGT2B7 Tchem Enzyme -2.31570 219.0 131
UDP-glucuronosyltransferase 2B15 UGT2B15 Tbio Enzyme -1.79589 61.5 83
UDP-glucuronosyltransferase 2B10 UGT2B10 Tbio Enzyme -1.28053 19.5 91
UDP-glucuronosyltransferase 3A1 UGT3A1 Tdark Enzyme -0.35624 1.99 37
UDP-glucuronosyltransferase 2B28 UGT2B28 Tbio Enzyme -0.88835 8.45 45
UDP-glucuronosyltransferase 2B17 UGT2B17 Tbio Enzyme -1.91917 91.6 20
UDP-glucuronosyltransferase 1-5 UGT1A5 Tdark Enzyme -1.05324 9.49 21
UDP-glucuronosyltransferase 1-3 UGT1A3 Tbio Enzyme -1.83933 63.3 13
UDP-glucuronosyltransferase 1-1 UGT1A1 Tchem Enzyme -2.95436 932.5 146
UDP-glucuronosyltransferase 2B11 UGT2B11 Tbio Enzyme -0.26858 1.79 52